Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Number of patients receiving VA therapy

From: Health services research of integrative oncology in palliative care of patients with advanced pancreatic cancer

  Total   Female   Male  
VA therapy in general 176 73.3 % 93 75.0 % 83 71.6 %
Subcutaneous total 157 89.2 % 82 88.2 % 75 90.4 %
Intravenous total 62 35.2 % 32 34.4 % 30 36.1 %
Intratumoral total 34 19.3 % 13 14.0 % 21 24.4 %
Other total 4 2.2 % 3 3.2 % 1 1.2 %
Subcutaneous only 93 52.8 % 55 59.1 % 38 45.8 %
Intravenous only 6 3.4 % 5 5.4 % 1 1.2 %
Intratumoral only 6 3.4 % 2 2.2 % 4 4.8 %
Subcutaneous/intravenous 38 21.6 % 17 18.3 % 21 25.3 %
Subcutaneous/intratumoral 10 5.7 % 1 1.1 % 9 10.8 %
Intravenous/intratumoral 1 0.6 %    1 1.2 %
Subcutaneous/intravenous/intratumoral 15 8.5 % 8 8.6 % 7 8.4 %
  1. The percentages in the first row refer to the total number of patients, other percentages refer to the number of patients receiving VA therapy